Ted Skolarus to Ketoconazole
This is a "connection" page, showing publications Ted Skolarus has written about Ketoconazole.
Connection Strength
1.163
-
Survival by first-line therapy and prognostic group among men with metastatic castration-resistant prostate cancer. Cancer Med. 2024 Jun; 13(12):e7334.
Score: 0.947
-
Differential adoption of castration-resistant prostate cancer treatment across facilities in a national healthcare system. Cancer Med. 2023 03; 12(6):6945-6955.
Score: 0.216